Abstract:function contributes to overall RV function and would provide prognostic insight into disease severity in patients with known or suspected PH.Methods: We retrospectively studied 331 consenting adult patients with known or suspected PH.We assessed the relationship between the quantitative RA measurement and severity of PH in our pre-capillary PH registry at our Clinic between January 2012 and January 2014.The components of RA function and the interaction of RA and RV contractility was assessed through the comprehensive quantitation of RA and RV deformation mechanics.Results: Of 331 patients, 22.6% had WHO functional class (Fc) I, 41.2% had Fc II, 32.9% had Fc III, and 3.1% had Fc IV.The mean age was 61±15 years, and 65.6% were women.We recorded 57 deaths (17.2%) during follow-up period.There was an increasing trend (p<0.05) in RA pressure, severe RA and RV dilatation, and PVR among patients with increased pulmonary artery systolic pressure (PASP).Interestingly, deceased patients had significantly lower in overall RA function; RA reservoir function (48±16% vs. 58±12%); RA passive conduit function (20±10% vs. 28±12%); and RA active pumping function (35±14% vs. 42±13%) (all p<0.0001).The mean value of RA longitudinal strain in PH patients was 51±20 (36±20% in deaths vs. 53±19% in alive group).Deceased patients had significantly lower in systolic atrial strain rate (1.43±0.55s -1 vs. 2.07±0.65 s -1 ), early diastolic strain rate (-0.87±5 s -1 vs. -1.24±0.55s -1 ) and late diastolic strain rate (-1.38±0.71s -1 vs. -1.86±0.78s -1 ) compared with alive group at follow up (all p<0.0001).A reduction in RA functions (reservoir and conduit), RA strain and strain rate were significantly associated with those with increased PASP and mortality (all p<0.0001).Although RA active pumping function is not significantly decreased with severity of PA systolic pressure (p=0.08), the contribution of RA active pumping function is increased with the severity of PASP (p<0.0001).Multivariate Cox regression analysis showed that RA reservoir function is statistically significant with mortality in PH patients even after adjusting for age, gender, functional capacity and RV function.Conclusions: All components of RA function and RA mechanics were decreased with RV dysfunction and severity of PA systolic pressure.A reservoir function were significantly associated with poor clinical outcomes in PH patients, regardless of RV function and functional capacity.

Efficacy and safety of the Aria pulmonary endovascular device in pulmonary hypertension

Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function

Impact of pulmonary hypertension on outcomes after TEER in patients suffering from mitral regurgitation

The Safety of Endothelin Receptor Antagonists in the Treatment of Pulmonary Arterial Hypertension

Prevalence and Prognostic Implications of Pulmonary Hypertension in Patients With Severe Aortic Regurgitation

Feasibility, Safety, and Efficacy of the Atrial Flow Regulator in Pediatric Patients: A Single-Center Experience

Echocardiographic Evaluation of Initial Ambrisentan Plus Phosphodiesterase Type 5 Inhibitor on Right Ventricular Pulmonary Artery Coupling in Severe Pulmonary Arterial Hypertension Patients

Right Ventricular Systolic to Diastolic Duration Ratio: A Novel Predictor of Outcome in Adult Idiopathic Pulmonary Arterial Hypertension.

Impact of rapid sequential combination therapy on distinct haemodynamic measures in newly diagnosed pulmonary arterial hypertension

Implantation of atrial flow regulator devices in patients with congenital heart disease and children with severe pulmonary hypertension or cardiomyopathy—an international multicenter case series

Pulmonary Hypertension: Intensification and Personalization of Combination Rx (PHoenix): A phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies

Does pulmonary endarterectomy improve the clinical conditions of patients with chronic thromboembolic pulmonary disease without pulmonary hypertension?

Hemodynamic Effects of Pulmonary Arterial Hypertension-Specific Therapy in Patients With Heart Failure With Preserved Ejection Fraction and With Combined Post- and Precapillay Pulmonary Hypertension

Right ventricular remodelling and long-term survival after pulmonary endarterectomy versus balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension

Pulmonary endarterectomy and balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: comparison of changes in hemodynamics and functional capacity

P4537Prolonged Right Ventricular Systolic to Diastolic Duration Ratio Predicts Mortality in Idiopathic Pulmonary Arterial Hypertension

Effects of pulmonary hypertension targeted therapy on haemodynamics in pulmonary arterial hypertension associated with adult congenital heart disease: a meta-analysis

The Safety of Endothelin Receptor Antagonists in the Treatment of Pulmonary Arterial Hypertension: Protocol for a Systemic Review and Network Meta-Analysis.

Balloon pulmonary angioplasty reverse right ventricular remodelling and dysfunction in patients with inoperable chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis

Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial

Atrial flow regulators for the treatment of pulmonary arterial hypertension: what does the future hold?